Global Artificial Intelligence in Diabetes Management Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027
Request for Sample
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
"Global Artificial Intelligence in Diabetes Management Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027" is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global artificial intelligence in diabetes management market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global artificial intelligence in diabetes management market report has been segmented on the basis of device type, technique type, and region.
Artificial intelligence (AI) is an area of computer science which emphasizes in creation of intelligent machines that work and react like humans. Artificial intelligence in healthcare uses an algorithms and software to approximate human cognition in analysis of complex medical data. Artificial intelligence is being used for a wide-range of healthcare and research purposes, including detection of disease, management of chronic conditions, delivery of health services, and drug discovery. In diabetes management, about Type 1 or Type 2 diabetes patients can be benefited through change in lifestyle, daily routine, and others in order to maintain blood glucose level. Keeping blood glucose level in balance stage, improves the health of diabetic patient and prevents long-term complications or short-term risks that come with blood sugars level.
Technological advancements in medical devices resulting in miniaturization of products, high number of patient pool suffering from diabetic disease and high internet penetration in developed countries are major factors expected to drive growth of the global artificial intelligence in diabetes management market. In addition, well-developed internet infrastructure in developed countries and increasing government spending on healthcare sector in order to facilitate the services are some other factors expected to support growth of the market. Moreover, patient centric approach and increasing use of smart monitoring devices in order to track health record are some other factors expected to support growth of the target market over the forecast period. Furthermore, increasing use of artificial intelligence for various diabetic research purpose is another major factor expected to support growth of the global market to certain extent.
However, high cost of devices is a major factor expected to hamper growth of the global market to certain extent.
Increasing investment for R&D activities by major players is expected to create new opportunities in terms of revenue for players operating in the target market over the forecast period. In addition, growing merger and acquisition activities and innovative product offerings by new major players in the market are other major factors expected to further support growth of the global market to certain extent.
The market in North America is expected to dominate the global artificial intelligence in diabetes management market and is expected to continue its dominance over the forecast period. This can be attributed to well-developed internet infrastructure, increasing government expenditure on healthcare sector, and presence of major players operating in the countries in this region. In addition, growing merger and acquisition activities among region international players is expected to further support the growth of the market. In 2017, according to International Diabetic Federation there are 33,517,033 diabetic patient in the US. Europe is expected to contribute significant revenue share to the global market. The market in Asia Pacific is expected witness fastest growth owing to high patient pool suffering from diabetics and increasing government expenditure on development of healthcare infrastructure.
Global Artificial Intelligence in Diabetes Management Market Segmentation:
By Device Type:
- Glucose Monitoring Devices
- Diagnostic Devices
- Insulin Delivery Devices
By Technique Type:
- Case-based Reasoning
- Intelligent Data Analysis
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Apple Inc.
- Glooko Inc.
- Google LLC
- IBM Corporation
- Vodafone Group Plc.
Request for TOC
Don't just take our word. We are trusted by these great companies!